AR002728A1 - Un procedimiento para inhibir la fotodescomposicion de 2-oxindol-1- carboxamidas 3-sustituidas y una composicion farmaceutica que comprende dichaoxindol-carboxamida asi inhibida. - Google Patents
Un procedimiento para inhibir la fotodescomposicion de 2-oxindol-1- carboxamidas 3-sustituidas y una composicion farmaceutica que comprende dichaoxindol-carboxamida asi inhibida.Info
- Publication number
- AR002728A1 AR002728A1 ARP960101956A AR10195696A AR002728A1 AR 002728 A1 AR002728 A1 AR 002728A1 AR P960101956 A ARP960101956 A AR P960101956A AR 10195696 A AR10195696 A AR 10195696A AR 002728 A1 AR002728 A1 AR 002728A1
- Authority
- AR
- Argentina
- Prior art keywords
- carboxamide
- substituted
- carboxamides
- inhibited
- inhibiting
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4883—Capsule finishing, e.g. dyeing, aromatising, polishing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Medicinal Preparation (AREA)
- Pyrane Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Polymerisation Methods In General (AREA)
- Macromonomer-Based Addition Polymer (AREA)
Abstract
La presente invención se refiere a un procedimiento para inhibir la fotodescomposición de 2-oxindol-1-carboxamidas 3-sustituidas de fórmula (I), yla forma enólica del mismo o una sal de base farmacéuticamente aceptable del mismo en la queX es H, Cl o F; Y es H o Cl; y R es bencilo o tienilo, cada unoopcionalmente sustituido con Cl o F; donde dicha carboxamida es un medicamento y dicha fotodescomposición es causada por una luz que procede de una fuenteluminosa, caracterizado porque un material fotoabsorbente es puesto en contacto íntimo con dicha carboxamida por medio del mezclado con ella,revistiéndola, o incorporándola para esto en forma de dosificación, por lo cual dicha luz de dicha fuente de luz es substancialmenteimpedida de incidir o deotra manera de degradar o descomponer dicha carboxamida. Particularmente dicha forma de dosificación es un comprimido o una cápsula. Además, la invención serefiere a una composición farmacéutica que comprende dicha oxindol-carboxamida así inhibida.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IB1995/000287 WO1996033701A1 (en) | 1995-04-24 | 1995-04-24 | Inhibiting photodecomposition of 3-substituted-2-oxindoles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR002728A1 true AR002728A1 (es) | 1998-04-29 |
Family
ID=36997502
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP960101956A AR002728A1 (es) | 1995-04-24 | 1996-03-28 | Un procedimiento para inhibir la fotodescomposicion de 2-oxindol-1- carboxamidas 3-sustituidas y una composicion farmaceutica que comprende dichaoxindol-carboxamida asi inhibida. |
Country Status (30)
| Country | Link |
|---|---|
| EP (1) | EP0827399A1 (es) |
| JP (1) | JPH10506635A (es) |
| KR (1) | KR100189585B1 (es) |
| CN (1) | CN1053667C (es) |
| AP (1) | AP607A (es) |
| AR (1) | AR002728A1 (es) |
| AU (1) | AU692378B2 (es) |
| BG (1) | BG100531A (es) |
| BR (1) | BR9602024A (es) |
| CO (1) | CO4700418A1 (es) |
| FI (1) | FI973988A0 (es) |
| HR (1) | HRP960194A2 (es) |
| HU (1) | HU216544B (es) |
| IL (1) | IL117969A0 (es) |
| IS (1) | IS4339A (es) |
| MA (1) | MA23848A1 (es) |
| NO (1) | NO961622L (es) |
| NZ (1) | NZ286432A (es) |
| OA (1) | OA10286A (es) |
| PE (1) | PE34397A1 (es) |
| RO (1) | RO113305B1 (es) |
| RU (1) | RU2109510C1 (es) |
| SG (1) | SG64924A1 (es) |
| SI (1) | SI9600133A (es) |
| SK (1) | SK51296A3 (es) |
| TR (1) | TR199600300A2 (es) |
| UA (1) | UA42739C2 (es) |
| WO (1) | WO1996033701A1 (es) |
| YU (1) | YU25096A (es) |
| ZA (1) | ZA963210B (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11246323B2 (en) | 2017-12-29 | 2022-02-15 | Kraft Foods Group Brands Llc | Oxidative stability of oil-in-water emulsions using natural stabilizers |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3136282A1 (de) * | 1981-09-12 | 1983-03-24 | Hoechst Ag | "verfahren zur stabilisierung photoinstabiler arzneistoffe sowie stabilisierte arzneizubereitungen" |
| HUT59592A (en) * | 1990-07-20 | 1992-06-29 | Egyt Gyogyszervegyeszeti Gyar | Process for the preparation of solid medical products |
| TW438798B (en) * | 1992-10-07 | 2001-06-07 | Pfizer | 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions |
-
1995
- 1995-04-24 FI FI973988A patent/FI973988A0/fi unknown
- 1995-04-24 WO PCT/IB1995/000287 patent/WO1996033701A1/en not_active Ceased
- 1995-04-24 EP EP95914494A patent/EP0827399A1/en not_active Ceased
- 1995-04-24 UA UA96041574A patent/UA42739C2/uk unknown
- 1995-04-24 SK SK512-96A patent/SK51296A3/sk unknown
- 1995-04-24 JP JP8532298A patent/JPH10506635A/ja active Pending
- 1995-04-24 RU RU96108120A patent/RU2109510C1/ru active
-
1996
- 1996-03-07 AP APAP/P/1996/000787A patent/AP607A/en active
- 1996-03-28 AR ARP960101956A patent/AR002728A1/es unknown
- 1996-04-10 TR TR96/00300A patent/TR199600300A2/xx unknown
- 1996-04-18 IL IL11796996A patent/IL117969A0/xx unknown
- 1996-04-19 IS IS4339A patent/IS4339A/is unknown
- 1996-04-19 SG SG1996009306A patent/SG64924A1/en unknown
- 1996-04-22 CN CN96105084A patent/CN1053667C/zh not_active Expired - Fee Related
- 1996-04-22 PE PE1996000275A patent/PE34397A1/es not_active Application Discontinuation
- 1996-04-22 RO RO96-00843A patent/RO113305B1/ro unknown
- 1996-04-22 CO CO96019210A patent/CO4700418A1/es unknown
- 1996-04-23 HU HU9601057A patent/HU216544B/hu not_active IP Right Cessation
- 1996-04-23 AU AU50851/96A patent/AU692378B2/en not_active Ceased
- 1996-04-23 KR KR1019960012356A patent/KR100189585B1/ko not_active Expired - Fee Related
- 1996-04-23 MA MA24209A patent/MA23848A1/fr unknown
- 1996-04-23 BG BG100531A patent/BG100531A/xx unknown
- 1996-04-23 NZ NZ286432A patent/NZ286432A/en unknown
- 1996-04-23 ZA ZA9603210A patent/ZA963210B/xx unknown
- 1996-04-23 NO NO961622A patent/NO961622L/no unknown
- 1996-04-23 HR HRPCT/IB95/00287A patent/HRP960194A2/hr not_active Application Discontinuation
- 1996-04-23 YU YU25096A patent/YU25096A/sh unknown
- 1996-04-24 SI SI9600133A patent/SI9600133A/sl not_active IP Right Cessation
- 1996-04-24 BR BR9602024A patent/BR9602024A/pt active Search and Examination
- 1996-04-24 OA OA60821A patent/OA10286A/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO2025027I1 (no) | Pharmaceutical mixture or association that includes as active ingredients: (1) ceftazidime or a salt thereof, and (2) avibactam or a pharmaceutically acceptable salt thereof - forlenget. | |
| AR028299A1 (es) | Una composicion farmaceutica que comprende nateglinida, un proceso para su preparacion y el uso de dicha composicion para la preparacion de un medicamento para el tratamiento de desordenes metabolicos, especialmente diabetes, o de una enfermedad o condicion asociada con diabetes. | |
| CA2339991A1 (en) | Microemulsions as solid dosage forms for oral administration | |
| TW200509905A (en) | Pharmaceutical compositions of atorvastatin | |
| MY128654A (en) | Liquid pharmaceutical composition containing an erythropoietin derivative | |
| EA200000245A1 (ru) | Быстро дезинтегрирующие таблетки метилцеллюлозы | |
| PT1041987E (pt) | Forma farmaceutica de dosagem oral, compreendendo uma combinacao de um agonista de opioide e naltrexona | |
| AR012717A1 (es) | Trihidrato de la sal de magnesio de s-omeprazol, proceso para su preparacion, composicion farmaceutica, y uso de dicho trihidrato para la fabricacion de medicamentos. | |
| SI1509232T1 (sl) | Kombinacija antagonista nmda in zaviralcev acetilholinesteraze za zdravljenje alzheimerjeve bolezni | |
| MA26516A1 (fr) | Tartrate d'un dipeptide substitue, procede pour sa preparation et compositions pharmaceutiques le contenant. | |
| BR0213355A (pt) | composições farmacêuticas | |
| BRPI0412557A (pt) | forma de dosagem farmacêutica de eventos cardiovasculares | |
| LT2001119A (en) | Pharmaceutical formulations comprising intranasal morphine and use thereof | |
| MXPA05003253A (es) | Nuevos derivados de pirimidinamida y el uso de los mismos. | |
| ATE230993T1 (de) | Pharmazeutische zusammensetzung zur behandlung von alkoholabhängigkeit, die opioid antagonisten mit nmda-rezeptorkomplex-modulatoren enthält | |
| UA85359C2 (ru) | Таблетка, содержащая гранулированный материал с kmd-3213 | |
| ATE273693T1 (de) | Proteinhaltige arzneimittel | |
| TW200503689A (en) | Pharmaceutical compositions of atorvastatin | |
| KR970061249A (ko) | 골다공증을 치료 또는 방지하기 위한 조성물 | |
| PL350568A1 (en) | N-(2-phenyl-4-aminobutyl)-1-naphtamides as antagonists of neurokinin 1 receptors | |
| HUP9901260A3 (en) | Optically active phenylpyrimidine derivative as analgesic agent, process for producing it, pharmaceutical composition containing it and its intermediate | |
| RU94040886A (ru) | Применение производных мелатонина для лечения нарушений сна, фармацевтическая композиция | |
| DE60134735D1 (de) | Neue neurokinin-antagonisten zum gebrauch als arzneimittel | |
| AR002728A1 (es) | Un procedimiento para inhibir la fotodescomposicion de 2-oxindol-1- carboxamidas 3-sustituidas y una composicion farmaceutica que comprende dichaoxindol-carboxamida asi inhibida. | |
| MA27662A1 (fr) | Procede pour la fabrication d'une composition pharmaceutique sous la forme de comprimes contenant un fibrate et comprimes obtenus selon le procede |